Cytogenetic risk stratification in myelodysplastic syndromes: Are we there yet?

Journal of Clinical Oncology

Volumn 30, Issue 21, 2012, Pages 2703-2704

  Pardanani, Animesh ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CYTOGENETICS; DISEASE FREE SURVIVAL; GENETIC RISK; HUMAN; KARYOTYPING; LETTER; METAPHYSIS; MOLECULAR GENETICS; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES;

EID: 84864051730     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.5033     Document Type: Letter

References (10)

1. Schanz J, Tüchler H, Solé F, et al: New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 30:820-829, 2012
2. Greenberg P, Cox C, LeBeau MM, et al: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079-2088, 1997 (Pubitemid 27132124)
3. Breems DA, Van Putten WL, De Greef GE, et al: Monosomal karyotype in acute myeloid leukemia: A better indicator of poor prognosis than a complex karyotype. J Clin Oncol 26:4791-4797, 2008
4. Vaidya R, Caramazza D, Begna KH, et al: Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival. Blood 117:5612-5615, 2011
5. Patnaik MM, Hanson CA, Hodnefield JM, et al: Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia 25:266-270, 2011
6. Valcarcel D, Adema V, Mallo M, et al: Prognostic impact of monosomal karyotype in patients with myelodysplastic syndrome and abnormal karyotype. A report from the Spanish group of MDS (GESMD). 53rd ASH Annual Meeting, San Diego, CA, December 10-13, 2011 (abstr 1724)
7. Bejar R, Stevenson K, Abdel-Wahab O, et al: Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364:2496-2506, 2011
8. Vardiman JW, Thiele J, Arber DA, et al: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 114:937-951, 2009
9. Ghaddar HM, Pierce S, Reed P, et al: Prognostic value of residual normal metaphases in acute myelogenous leukemia patients presenting with abnormal karyotype. Leukemia 9:779-782, 1995
10. Xie B, Othus M, Medeiros BC, et al: Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype. Haematologica 96:631-632, 2011